Fundz

Rgenta Therapeutics, Inc.

Cambridge, Massachusetts, United States · Biotechnology, Health Care, Other

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique

Key facts

Headquarters
Cambridge, Massachusetts, United States
Employees
33
Industries
Biotechnology, Health Care, Other
Status
Private
Website
rgentatx.com
LinkedIn
Company page

Recent activity at Rgenta Therapeutics, Inc.

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Rgenta Therapeutics, Inc. funding history

DateRoundAmount
Oct 2026Venture$41.9M
Nov 2022Series A$52.0M
Feb 2022Venture$8.9M
Feb 2020Venture$6.0M

Leadership

  • Samuel, Senior Director
  • Hualin Xi, Executive Officer, Director
  • Zhiping Weng, Director
  • Fei Shen, Director
  • Sun Linghao, Director
  • Judith Li, Director
  • Debasish Roychowdhury, Director
  • Hongbo Lu, Director
  • Martin Heidecker, Director

Verified email and direct lines for Rgenta Therapeutics, Inc.’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Rgenta Therapeutics, Inc. files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Rgenta Therapeutics, Inc. in the news

Companies similar to Rgenta Therapeutics, Inc.

About Rgenta Therapeutics, Inc.: questions and answers

What does Rgenta Therapeutics, Inc. do?

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique

Where is Rgenta Therapeutics, Inc. headquartered?

Rgenta Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

How many employees does Rgenta Therapeutics, Inc. have?

Rgenta Therapeutics, Inc. has about 33 employees.

Has Rgenta Therapeutics, Inc. raised funding?

Yes. Fundz has recorded 4 funding events for Rgenta Therapeutics, Inc.. The most recent, $41.9M, was in Oct 2026.

What is the latest news on Rgenta Therapeutics, Inc.?

On Oct 19, 2026, Rgenta Therapeutics

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Rgenta Therapeutics, Inc. across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.